Collectively, the miR-21–PTEN–PI3K/AKT axis orchestrates both oncogenic signaling and immune evasion, establishing miR-21-5p as a dual driver of tumor progression and immunotherapy resistance in CRC. This evidence concerns the gene AKT1 and neoplasm.